Key PointsMedtronic recently completed a key spinoff of its diabetes segment.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
Veytics Intelligence
Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?
